arginyl-glycyl-aspartic acid has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achilefu, S; Gu, Y; Li, S; Liu, Y; Rui, Y; Tang, L | 1 |
| Li, H; Li, K; Wang, H; Zhang, Q; Zhang, Y; Zheng, J | 1 |
| Gao, J; Han, L; Jia, Q; Kang, X; Li, X; Lou, Y; Wen, Z; Yang, J; Zou, L | 1 |
| Barnett, J; Cuthbertson, A; Morrison, MS; Ricketts, SA; Tessier, J; Wedge, SR | 1 |
| Feng, J; Jia, HL; Li, HM; Li, XD; Zhang, JY | 1 |
| Liu, S; Liu, X; Sui, A; Wang, Z; Yao, R; Zhang, H; Zhou, Q | 1 |
| Eriksson, M; Hakkarainen, T; Hemminki, A; Kanerva, A; Kangasniemi, L; Raki, M; Ranki, T; Salo, J; Sarkioja, M | 1 |
7 other study(ies) available for arginyl-glycyl-aspartic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Doxorubicin; Genetic Therapy; Gold; Humans; Lung Neoplasms; Metal Nanoparticles; Mice, Nude; MicroRNAs; Oligopeptides; Oncogene Proteins, Fusion; Photochemotherapy | 2018 |
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Oligopeptides | 2015 |
Antitumor activity of recombinant RGD-IFN-α2a-core fusion protein in vitro.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cloning, Molecular; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Interferon-alpha; Lung Neoplasms; Oligopeptides; Recombinant Fusion Proteins | 2017 |
Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Mice; Neoplasms; Oligopeptides; Paclitaxel; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Tissue Distribution; Triazoles | 2009 |
[Comparison of the biodistribution of four contrast agents in nude mice bearing NCI-H358 human lung cancer and evaluation of their value in diagnostic imaging].
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thiocarbamates; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Escherichia coli; Humans; Integrin alphaVbeta3; Lung Neoplasms; Oligopeptides; Poly(ADP-ribose) Polymerases; Receptors, Vitronectin; Recombinant Fusion Proteins; TNF-Related Apoptosis-Inducing Ligand | 2012 |
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.
Topics: Adenoviridae; Animals; Capsid; Carcinoma, Non-Small-Cell Lung; Female; Fluorometry; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Inbred Strains; Oligopeptides; Oncolytic Virotherapy; Receptors, Virus; Virus Replication | 2006 |